It’s no surprise that developers of COVID-19 vaccines had healthy profits in 2021. Most of the fastest-growing pharma companies in 2021 saw a COVID-19 therapy of some type contribute to their bottom line. Nevertheless, it remains difficult to fathom that BioNTech (Nasdaq:BNTX) reported annual revenue growth of 3,834.4% last year, making it the fastest-growing pharma companies…